|
DE1795183B1
(de)
|
1968-08-20 |
1972-07-20 |
Thomae Gmbh Dr K |
5,11-Dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-on-derivate und Arzneimittel
|
|
US4172831A
(en)
|
1974-11-26 |
1979-10-30 |
Lilly Industries Limited |
Thieno-benzodiazepines
|
|
US3953430A
(en)
|
1975-02-24 |
1976-04-27 |
American Cyanamid Company |
Substituted benzodiazepin-10-ones and method of use
|
|
US4168269A
(en)
|
1978-04-12 |
1979-09-18 |
American Cyanamid Company |
Substituted thieno-benzodiazepines
|
|
US4381301A
(en)
|
1980-05-07 |
1983-04-26 |
Byk Gulden Lomberg Chemische Fabrik Gmbh |
Substituted tricyclic thieno compounds, their synthesis, their use, their compositions and their medicaments
|
|
US4933438A
(en)
|
1984-02-29 |
1990-06-12 |
University Of Florida |
Brain-specific analogues of centrally acting amines
|
|
US6150354A
(en)
|
1987-01-15 |
2000-11-21 |
Bonnie Davis |
Compounds for the treatment of Alzheimer's disease
|
|
WO1989005644A2
(en)
|
1987-12-22 |
1989-06-29 |
Byk Gulden Lomberg Chemische Fabrik Gmbh |
Thienotricyclene for the treatment of bronchial diseases
|
|
US5344832A
(en)
*
|
1990-01-10 |
1994-09-06 |
The Board Of Supervisors Of Louisiana University And Agricultural And Mechanical College |
Method for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hyperglycemia in vertebrates
|
|
US5585347A
(en)
*
|
1988-05-10 |
1996-12-17 |
Ergo Science Incorporated |
Methods for the determination and adjustment of prolactin daily rhythms
|
|
US5668155A
(en)
*
|
1988-05-10 |
1997-09-16 |
The General Hospital Corporation |
Administration of pirenzepine, methyl scopolamine and other muscarinic receptor antagonists for treatment of lipid metabolism disorders
|
|
IE61928B1
(en)
|
1988-11-29 |
1994-11-30 |
Boots Co Plc |
Treatment of obesity
|
|
US5133974A
(en)
|
1989-05-05 |
1992-07-28 |
Kv Pharmaceutical Company |
Extended release pharmaceutical formulations
|
|
US5126324A
(en)
*
|
1990-06-07 |
1992-06-30 |
Genentech, Inc. |
Method of enhancing growth in patients using combination therapy
|
|
EP0584185B1
(en)
|
1991-05-14 |
1999-08-11 |
Ernir Snorrason |
Treatment of fatigue syndrome with cholinesterase inhibitors
|
|
IT1250421B
(it)
|
1991-05-30 |
1995-04-07 |
Recordati Chem Pharm |
Composizione farmaceutica a rilascio controllato con proprieta' bio-adesive.
|
|
US5324832A
(en)
|
1991-07-03 |
1994-06-28 |
The United States Of America As Represented By The Department Of Health And Human Services |
Muscarinic antagonists
|
|
US6537579B1
(en)
|
1993-02-22 |
2003-03-25 |
American Bioscience, Inc. |
Compositions and methods for administration of pharmacologically active compounds
|
|
FR2710265B1
(fr)
|
1993-09-22 |
1995-10-20 |
Adir |
Composition pharmaceutique bioadhésive pour la libération contrôlée de principes actifs.
|
|
US6548084B2
(en)
|
1995-07-20 |
2003-04-15 |
Smithkline Beecham Plc |
Controlled release compositions
|
|
US6245347B1
(en)
|
1995-07-28 |
2001-06-12 |
Zars, Inc. |
Methods and apparatus for improved administration of pharmaceutically active compounds
|
|
DE19541260A1
(de)
|
1995-11-06 |
1997-05-07 |
Lohmann Therapie Syst Lts |
Therapeutische Zubereitung zur transdermalen Applikation von Wirkstoffen durch die Haut
|
|
US6512010B1
(en)
|
1996-07-15 |
2003-01-28 |
Alza Corporation |
Formulations for the administration of fluoxetine
|
|
PT863136E
(pt)
|
1997-02-25 |
2004-01-30 |
Akzo Nobel Nv |
Derivados de azetidina e de pirrolidina
|
|
US5795895A
(en)
*
|
1997-06-13 |
1998-08-18 |
Anchors; J. Michael |
Combination anorexiant drug therapy for obesity using phentermine and an SSRI drug
|
|
CA2301883A1
(en)
|
1997-09-11 |
1999-03-18 |
Nycomed Danmark A/S |
Modified release multiple-units compositions of non-steroid anti-inflammatory drug substances (nsaids)
|
|
US6624200B2
(en)
|
1998-08-25 |
2003-09-23 |
Columbia Laboratories, Inc. |
Bioadhesive progressive hydration tablets
|
|
SE9703375D0
(sv)
|
1997-09-18 |
1997-09-18 |
Astra Ab |
A new combination
|
|
US6607751B1
(en)
|
1997-10-10 |
2003-08-19 |
Intellipharamaceutics Corp. |
Controlled release delivery device for pharmaceutical agents incorporating microbial polysaccharide gum
|
|
US6403597B1
(en)
|
1997-10-28 |
2002-06-11 |
Vivus, Inc. |
Administration of phosphodiesterase inhibitors for the treatment of premature ejaculation
|
|
US6248864B1
(en)
|
1997-12-31 |
2001-06-19 |
Adherex Technologies, Inc. |
Compounds and methods and modulating tissue permeability
|
|
AU766219B2
(en)
*
|
1998-02-02 |
2003-10-09 |
1149336 Ontario Inc. |
Method of regulating glucose metabolism, and reagents related thereto
|
|
US6613358B2
(en)
|
1998-03-18 |
2003-09-02 |
Theodore W. Randolph |
Sustained-release composition including amorphous polymer
|
|
US6312717B1
(en)
|
1998-07-07 |
2001-11-06 |
Bristol-Myers Squibb Company |
Method for treatment of anxiety and depression
|
|
US20020009478A1
(en)
|
1998-08-24 |
2002-01-24 |
Douglas Joseph Dobrozsi |
Oral liquid mucoadhesive compositions
|
|
US6331571B1
(en)
|
1998-08-24 |
2001-12-18 |
Sepracor, Inc. |
Methods of treating and preventing attention deficit disorders
|
|
SE9802864D0
(sv)
|
1998-08-27 |
1998-08-27 |
Pharmacia & Upjohn Ab |
Transdermally administered tolterodine as antimuscarinic agent for the treatment of overactive bladder
|
|
BR9914251A
(pt)
|
1998-10-01 |
2001-06-19 |
Novartis Ag |
Formulações orais de liberação sustentada
|
|
US6248363B1
(en)
|
1999-11-23 |
2001-06-19 |
Lipocine, Inc. |
Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
|
|
FR2792527B1
(fr)
|
1999-04-22 |
2004-08-13 |
Ethypharm Lab Prod Ethiques |
Microgranules de ketoprofene, procede de preparation et compositions pharmaceutiques
|
|
US6541020B1
(en)
|
1999-07-09 |
2003-04-01 |
Trimeris, Inc. |
Methods and compositions for administration of therapeutic reagents
|
|
US6562375B1
(en)
|
1999-08-04 |
2003-05-13 |
Yamanouchi Pharmaceuticals, Co., Ltd. |
Stable pharmaceutical composition for oral use
|
|
PT1207860E
(pt)
|
1999-09-02 |
2008-01-24 |
Nostrum Pharmaceuticals Inc |
Formulação de peletes de libertação controlada
|
|
US6544548B1
(en)
|
1999-09-13 |
2003-04-08 |
Keraplast Technologies, Ltd. |
Keratin-based powders and hydrogel for pharmaceutical applications
|
|
US6403657B1
(en)
*
|
1999-10-04 |
2002-06-11 |
Martin C. Hinz |
Comprehensive pharmacologic therapy for treatment of obesity
|
|
US6080736A
(en)
|
1999-10-27 |
2000-06-27 |
Janus Pharmaceuticals, Inc. |
Methods and compositions for treating and preventing anxiety and anxiety disorders using optically pure (R) tofisopam
|
|
US6461631B1
(en)
|
1999-11-16 |
2002-10-08 |
Atrix Laboratories, Inc. |
Biodegradable polymer composition
|
|
WO2001047501A1
(en)
|
1999-12-29 |
2001-07-05 |
Nanodelivery, Inc. |
Drug delivery system exhibiting permeability control
|
|
US6589549B2
(en)
|
2000-04-27 |
2003-07-08 |
Macromed, Incorporated |
Bioactive agent delivering system comprised of microparticles within a biodegradable to improve release profiles
|
|
US6524621B2
(en)
|
2000-05-01 |
2003-02-25 |
Aeropharm Technology Inc. |
Core formulation
|
|
WO2002022579A2
(en)
*
|
2000-09-11 |
2002-03-21 |
Sepracor, Inc. |
Antipsychotic sulfonamide-heterocycles, and methods of use thereof
|
|
US6482440B2
(en)
|
2000-09-21 |
2002-11-19 |
Phase 2 Discovery, Inc. |
Long acting antidepressant microparticles
|
|
US6524615B2
(en)
|
2001-02-21 |
2003-02-25 |
Kos Pharmaceuticals, Incorporated |
Controlled release pharmaceutical composition
|
|
EP3173082A1
(en)
*
|
2002-05-17 |
2017-05-31 |
Duke University |
Method for treating obesity
|
|
US20040204472A1
(en)
*
|
2003-03-04 |
2004-10-14 |
Pharmacia Corporation |
Treatment and prevention of obesity with COX-2 inhibitors alone or in combination with weight-loss agents
|
|
US20050143350A1
(en)
|
2003-11-19 |
2005-06-30 |
Seed John C. |
Combination drug therapy to treat obesity
|
|
US20050226920A1
(en)
*
|
2004-04-13 |
2005-10-13 |
Kirk Voelker |
Method of decreasing nicotine withdrawal symptoms during smoking cessation.
|
|
BRPI0506807A
(pt)
*
|
2004-04-22 |
2007-05-29 |
Mor Research Applic Ltd |
método de gerenciamento de consumo de alimento e composição farmacológica
|
|
EP1778244A1
(en)
|
2004-08-05 |
2007-05-02 |
Acadia Pharmaceuticals Inc. |
Use of n-desmethylclozapine to treat human neuropsychiatric disease
|
|
JP2008537961A
(ja)
*
|
2005-04-15 |
2008-10-02 |
ボード、オブ、トラスティーズ、オブ、ミシガン、ステイト、ユニバーシティ |
Ｇｐｃｒモジュレーター
|
|
US8859585B2
(en)
|
2005-05-25 |
2014-10-14 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Scopolamine for the treatment of depression and anxiety
|
|
US9697668B2
(en)
|
2006-03-14 |
2017-07-04 |
Nxp B.V. |
Automatically configurable smart card and method of automatically configuring a smart card
|
|
UA98938C2
(ru)
|
2006-06-16 |
2012-07-10 |
Теракос, Инк. |
Лечение психологических состояний с применением антагонистов мускариновых рецепторов м1
|
|
US7893053B2
(en)
|
2006-06-16 |
2011-02-22 |
Theracos, Inc. |
Treating psychological conditions using muscarinic receptor M1 antagonists
|